Xipamide
- Generic Name
- Xipamide
- Drug Type
- Small Molecule
- Chemical Formula
- C15H15ClN2O4S
- CAS Number
- 14293-44-8
- Unique Ingredient Identifier
- 4S9EY0NUEC
- Associated Conditions
- Edema, Hypertension, Mild to Moderate Hypertension, Severe Hypertension
Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
- First Posted Date
- 2023-04-12
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Stratpharma AG
- Target Recruit Count
- 344
- Registration Number
- NCT05810194
- Locations
- 🇺🇸
University of California, Los Angeles, California, United States
Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
Phase 2
Active, not recruiting
- Conditions
- Cancer of the Head and Neck
- Interventions
- Drug: Dermaprazole
- First Posted Date
- 2021-04-29
- Last Posted Date
- 2024-08-22
- Target Recruit Count
- 6
- Registration Number
- NCT04865731
- Locations
- 🇺🇸
Mays Cancer Center, San Antonio, Texas, United States
Steroid-reducing Effects of Crisaborole
Phase 4
Completed
- Conditions
- Atopic DermatitisEczema
- Interventions
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 24
- Registration Number
- NCT03832010
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis
- First Posted Date
- 2015-08-27
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- ProTechSure Scientific, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02534129
- Locations
- 🇺🇸
Poudre Valley Health System, Fort Collins, Colorado, United States
Post Treatment Care After Chemical Peel or Laser Resurfacing
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2013-10-01
- Lead Sponsor
- Healthpoint
- Registration Number
- NCT01135290
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Topical Therapy for Prevention of Infections in Preterm Infants
Phase 4
Completed
- Conditions
- Skin Diseases
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2005-09-13
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 600
- Registration Number
- NCT00162747
- Locations
- 🇧🇩
Dhaka Shishu Hospital, Dhaka, Bangladesh
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath